Parnell Pharmaceuticals Holdings Ltd. announced changes in the structure of its board of directors including the engagement of Egon Zhender to identify and assist in the appointment of additional high caliber independent directors and at the same time, Parnell announced that it has accepted the resignation of Thomas Duley, Phyllis Gardner, and David Greenwood as directors of the company effective September 28, 2015. With the assistance of Egon Zhender, the company intends to appoint additional independent directors in the near term each of whom will have the ability and experience to help guide the company through its anticipated rapid growth in the coming years.